Oscar Health, Inc. (NYSE:OSCR) Given Consensus Recommendation of “Hold” by Brokerages

Oscar Health, Inc. (NYSE:OSCR) has been given a consensus recommendation of “Hold” by the ten analysts that are covering the stock, Marketbeat reports. Two investment analysts have rated the stock with a sell recommendation, six have assigned a hold recommendation and two have assigned a buy recommendation to the company. The average 1 year price target among analysts that have issued a report on the stock in the last year is $16.8750.

Several brokerages recently weighed in on OSCR. UBS Group reaffirmed a “neutral” rating and set a $15.00 price target on shares of Oscar Health in a report on Wednesday, February 11th. Stephens initiated coverage on shares of Oscar Health in a research note on Thursday, December 11th. They issued an “equal weight” rating and a $17.00 price objective on the stock. Raymond James Financial upgraded shares of Oscar Health from a “market perform” rating to an “outperform” rating and set a $18.00 price objective for the company in a research report on Thursday, February 12th. Piper Sandler upgraded shares of Oscar Health from a “neutral” rating to an “overweight” rating and raised their target price for the stock from $13.00 to $25.00 in a research note on Tuesday, November 25th. Finally, Weiss Ratings reaffirmed a “sell (d)” rating on shares of Oscar Health in a report on Thursday, January 22nd.

Insider Buying and Selling

In related news, insider Mario Schlosser sold 23,038 shares of the firm’s stock in a transaction dated Thursday, January 8th. The shares were sold at an average price of $17.65, for a total value of $406,620.70. Following the completion of the sale, the insider owned 350,180 shares in the company, valued at $6,180,677. This trade represents a 6.17% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Insiders have sold a total of 138,835 shares of company stock valued at $2,298,269 in the last three months. 24.39% of the stock is owned by company insiders.

Hedge Funds Weigh In On Oscar Health

A number of large investors have recently modified their holdings of the business. Envestnet Asset Management Inc. grew its holdings in Oscar Health by 200.9% during the second quarter. Envestnet Asset Management Inc. now owns 30,210 shares of the company’s stock worth $648,000 after acquiring an additional 20,171 shares during the period. Udine Wealth Management Inc. boosted its position in shares of Oscar Health by 138.4% during the 3rd quarter. Udine Wealth Management Inc. now owns 146,555 shares of the company’s stock worth $2,774,000 after purchasing an additional 85,083 shares in the last quarter. Q Fund Management Hong Kong Ltd acquired a new position in shares of Oscar Health during the 3rd quarter worth $5,940,000. Jump Financial LLC grew its stake in shares of Oscar Health by 798.3% during the 2nd quarter. Jump Financial LLC now owns 1,441,506 shares of the company’s stock worth $30,906,000 after purchasing an additional 1,281,032 shares during the period. Finally, State of Michigan Retirement System purchased a new position in shares of Oscar Health in the 3rd quarter valued at about $27,448,000. 75.70% of the stock is owned by hedge funds and other institutional investors.

Oscar Health Stock Performance

Shares of OSCR stock opened at $12.98 on Friday. The stock’s 50-day moving average price is $14.56 and its 200 day moving average price is $16.50. The company has a quick ratio of 0.96, a current ratio of 0.96 and a debt-to-equity ratio of 0.44. The stock has a market capitalization of $3.86 billion, a PE ratio of -7.46 and a beta of 1.91. Oscar Health has a 52-week low of $11.20 and a 52-week high of $23.80.

Oscar Health (NYSE:OSCR) last posted its quarterly earnings data on Tuesday, February 10th. The company reported ($1.24) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.92) by ($0.32). The company had revenue of $2.81 billion for the quarter, compared to analyst estimates of $3.12 billion. Oscar Health had a negative return on equity of 39.35% and a negative net margin of 3.79%.The firm’s revenue was up 17.3% compared to the same quarter last year. During the same period in the previous year, the business posted ($0.62) earnings per share. As a group, equities research analysts forecast that Oscar Health will post 0.69 EPS for the current year.

Oscar Health Company Profile

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.